electroCore (ECOR) Net Income towards Common Stockholders (2017 - 2026)
electroCore (ECOR) posted Net Income towards Common Stockholders of -$3.1 million for Q2 2026, up 41.97% on a QoQ basis from -$5.3 million in Q1 2026, and up 16.67% year-over-year from -$2.6 million in Q2 2025.
Powered by 
Analysis
electroCore (ECOR) Net Income towards Common Stockholders (2017 - 2026) Analysis & Trends
electroCore has reported Net Income towards Common Stockholders for 10 years, with the latest figure at -$3.1 million in Q2 2026.
- On a quarterly basis, Net Income towards Common Stockholders rose 16.67% year-over-year to -$3.1 million in Q2 2026; TTM through Jun 2026 was -$11.8 million, a 10.69% increase from a year earlier, with the FY2025 full-year figure at -$11.0 million, up 7.19% from the prior year.
- Net Income towards Common Stockholders was -$3.1 million for Q2 2026 at electroCore, up from -$5.3 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was -$100000.0 in Q4 2025, with the low at -$5.9 million in Q1 2023.
- Average Net Income towards Common Stockholders over 5 years is -$4.0 million, with a median of -$3.9 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2025: Net Income towards Common Stockholders sank 84.42% in 2022, then jumped 96.9% in 2025.
- Over 5 years, Net Income towards Common Stockholders stood at -$5.8 million in 2022, then soared by 30.36% to -$4.0 million in 2023, then rose by 19.94% to -$3.2 million in 2024, then surged by 96.9% to -$100000.0 in 2025, then slumped by 2959.0% to -$3.1 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$3.1 million (Q2 2026), -$5.3 million (Q1 2026), and -$100000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 127.52 Bn | 122.30 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 117.07 Bn | 108.26 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 103.72 Bn | 100.25 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 907.00 Mn |
| 6 | Edwards Lifesciences | 49.71 Bn | 45.45 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Alcon | 33.00 Bn | 31.55 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.13 Bn | 30.18 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 201.00 Mn |
| 10 | electroCore | 85.67 Mn | 75.63 Mn | 8.18 Mn | -3.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.06 Mn |
| Mar 31, 2026 | -5.27 Mn |
| Dec 31, 2025 | -100,000.00 |
| Sep 30, 2025 | -3.41 Mn |
| Jun 30, 2025 | -3.67 Mn |
| Mar 31, 2025 | -3.86 Mn |
| Dec 31, 2024 | -3.23 Mn |
| Sep 30, 2024 | -2.50 Mn |
| Jun 30, 2024 | -2.66 Mn |
| Mar 31, 2024 | -3.51 Mn |
| Dec 31, 2023 | -4.03 Mn |
| Sep 30, 2023 | -4.03 Mn |
| Jun 30, 2023 | -4.90 Mn |
| Mar 31, 2023 | -5.87 Mn |
| Dec 31, 2022 | -5.79 Mn |
| Sep 30, 2022 | -5.45 Mn |
| Jun 30, 2022 | -5.34 Mn |
| Mar 31, 2022 | -5.58 Mn |
| Dec 31, 2021 | -4.95 Mn |
| Sep 30, 2021 | -3.99 Mn |